19 results
8-K
EX-99.2
AEMD
Aethlon Medical Inc
19 Sep 22
Departure of Directors or Certain Officers
5:00pm
;
potential facility contamination by microorganisms or viruses;
updating of manufacturing specifications;
product quality success rates and yields
8-K
EX-1.1
htwf o7j1pu3
24 Mar 22
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-99.1
pfb27l9old6qbchczyil
11 Jun 21
Securities Purchase Agreement
5:28pm
424B5
akjzjoxw1opcq 25dmp
11 Jun 21
Prospectus supplement for primary offering
5:27pm
8-K
EX-1.1
owt5l7 ug
22 Mar 21
Entry into a Material Definitive Agreement
5:02pm
424B5
4pv zsfj6qas6veu
22 Mar 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-10.1
ii9p94lgly
17 Jan 20
Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:29pm
8-K
EX-10.1
9gkf5epr
7 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
l8syvb1689n9sxhj
16 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
bb07iwd8er xjt1f0isp
20 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
lvdlmxvdypd2xoklo3
6 Nov 13
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next